Gamma-catenin expression is reduced or absent in a subset of human non-small cell lung cancers, and its re-expression inhibits cell growth.
Winn
Robert A
RA
Veterans Administration Medical Center, Denver, Denver, CO 80262, USA. robert.winn@uchsc.edu
Heasley
Lynn E
LE
D001374:Azacitidine / Q000031:analogs & derivatives* / Q000494:pharmacology; D002289:Carcinoma, Non-Small-Cell Lung / Q000378:metabolism*; D002455:Cell Division / Q000502:physiology; D045744:Cell Line, Tumor; D003598:Cytoskeletal Proteins / Q000378:metabolism*; D015254:DNA Modification Methylases / Q000037:antagonists & inhibitors; D000077209:Decitabine; D051180:Desmoplakins; D006801:Humans; D006877:Hydroxamic Acids / Q000494:pharmacology; D008175:Lung Neoplasms / Q000378:metabolism*; D009363:Neoplasm Proteins / Q000378:metabolism; D015534:Trans-Activators / Q000378:metabolism; D051176:beta Catenin; D051185:gamma Catenin
C495270:CTNNB1 protein, human; D003598:Cytoskeletal Proteins; D051180:Desmoplakins; D006877:Hydroxamic Acids; C495292:JUP protein, human; D009363:Neoplasm Proteins; D015534:Trans-Activators; D051176:beta Catenin; D051185:gamma Catenin; C012589:trichostatin A; D000077209:Decitabine; D015254:DNA Modification Methylases; D001374:Azacitidine